Renaissance Technologies - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$10,251
-25.3%
381,500
-0.9%
0.02%
-15.0%
Q2 2023$13,726
+84.6%
384,900
+31.5%
0.02%
+100.0%
Q1 2023$7,437
-62.9%
292,800
-40.7%
0.01%
-63.0%
Q4 2022$20,029
-99.9%
493,800
-34.6%
0.03%
-22.9%
Q3 2022$24,966,000
+60.8%
755,400
+71.3%
0.04%
+94.4%
Q2 2022$15,528,000
-11.2%
441,000
+16.0%
0.02%
-14.3%
Q1 2022$17,490,000
+417.9%
380,300
+603.0%
0.02%
+425.0%
Q3 2021$3,377,000
-77.2%
54,100
-69.8%
0.00%
-78.9%
Q2 2021$14,841,000
-7.4%
179,200
-25.8%
0.02%
-5.0%
Q1 2021$16,020,000
-16.4%
241,600
-63.7%
0.02%
+5.3%
Q1 2020$19,172,000
-58.2%
666,400
-7.7%
0.02%
-45.7%
Q4 2019$45,815,000
+147.2%
722,300
+9.8%
0.04%
+118.8%
Q3 2019$18,531,000
-11.3%
657,600
-16.6%
0.02%
-11.1%
Q2 2019$20,903,000
+568.5%
788,800
+362.9%
0.02%
+500.0%
Q1 2019$3,127,000
+416.0%
170,400
-54.5%
0.00%
+200.0%
Q2 2017$606,000374,1640.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders